Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Int J Mol Sci ; 24(22)2023 Nov 14.
Artigo em Inglês | MEDLINE | ID: mdl-38003507

RESUMO

Glioblastoma is the most common malignant primary central nervous system tumor and one of the most debilitating cancers. The prognosis of patients with glioblastoma remains poor, and the management of this tumor, both in its primary and recurrent forms, remains suboptimal. Despite the tremendous efforts that are being put forward by the research community to discover novel efficacious therapeutic agents and modalities, no major paradigm shifts have been established in the field in the last decade. However, this does not mirror the abundance of relevant findings and discoveries made in preclinical glioblastoma research. Hence, developing and utilizing appropriate preclinical models that faithfully recapitulate the characteristics and behavior of human glioblastoma is of utmost importance. Herein, we offer a holistic picture of the evolution of preclinical models of glioblastoma. We further elaborate on the commonly used in vitro and vivo models, delving into their development, favorable characteristics, shortcomings, and areas of potential improvement, which aids researchers in designing future experiments and utilizing the most suitable models. Additionally, this review explores progress in the fields of humanized and immunotolerant mouse models, genetically engineered animal models, 3D in vitro models, and microfluidics and highlights promising avenues for the future of preclinical glioblastoma research.


Assuntos
Neoplasias Encefálicas , Glioblastoma , Animais , Camundongos , Humanos , Glioblastoma/patologia , Neoplasias Encefálicas/terapia , Neoplasias Encefálicas/tratamento farmacológico , Modelos Animais de Doenças
2.
World Neurosurg ; 179: 144-145, 2023 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-37597664

RESUMO

Synovial cysts of the spine are degenerative cystic lesions that can lead to severe symptoms secondary to compression of the spinal cord, individual nerve roots, and/or the cauda equina. Some believe the etiology of this entity is related to increased motion across the facet joint and instability. We report a case of a lumbar synovial cyst located at the same level as a previously inserted spinous process fusion device. This case illustrates that, unlike a transpedicular instrumented fusion where the risk of synovial cyst formation is zero, a spinal process fusion can still lead to synovial cyst formation likely due to persistent micromotion across that segment.


Assuntos
Fusão Vertebral , Cisto Sinovial , Humanos , Vértebras Lombares/diagnóstico por imagem , Vértebras Lombares/cirurgia , Vértebras Lombares/patologia , Laminectomia/efeitos adversos , Fusão Vertebral/efeitos adversos , Descompressão Cirúrgica/efeitos adversos , Cisto Sinovial/diagnóstico por imagem , Cisto Sinovial/cirurgia , Cisto Sinovial/complicações
3.
Eur J Neurol ; 30(9): 2912-2918, 2023 09.
Artigo em Inglês | MEDLINE | ID: mdl-37350369

RESUMO

The widespread use of magnetic resonance imaging (MRI) has led to an increase in incidental findings in the central nervous system. Radiologically isolated syndrome (RIS) is a condition where imaging reveals lesions suggestive of demyelinating disease without any clinical episodes consistent with multiple sclerosis (MS). The prognosis for RIS patients is uncertain, with some remaining asymptomatic while others progress to MS. Several risk factors for disease progression have been identified, including male sex, younger age at diagnosis, and spinal cord lesions. This article reviews two promising biomarkers, the central vein sign (CVS) and the paramagnetic rim sign (PRS), and their potential role in the diagnosis and prognosis of MS and RIS. Both CVS and PRS have been shown to be accurate diagnostic markers in MS, with high sensitivity and specificity, and have been useful in distinguishing MS from other disorders. Further research is needed to validate these findings and determine the clinical utility of these biomarkers in routine practice.


Assuntos
Doenças Desmielinizantes , Esclerose Múltipla , Humanos , Masculino , Esclerose Múltipla/diagnóstico , Doenças Desmielinizantes/patologia , Imageamento por Ressonância Magnética/métodos , Encéfalo/patologia , Prognóstico
4.
J Clin Neurosci ; 74: 81-86, 2020 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-32007375

RESUMO

INTRODUCTION: The Montreal Cognitive Assessment (MoCA), a neuropsychological tool for cognitive decline screening is widely used. In the absence of normative data in Lebanon, this study offers normative data for the MoCA in Lebanese community-dwelling older people and compare scores to those of other countries. METHODS: 164 literate subjects aged 60 and above were recruited to complete the MoCA. RESULTS: The mean MoCA score observed (24.20 points) was lower than that for normal controls (27.4 points) in the original validation study of the MoCA. Regression analysis showed that fewer years of education were associated with lower MoCA scores (p < .000). CONCLUSIONS: This study presents normative data and the findings suggest that cultural differences are evident in cognitive testing.


Assuntos
Testes de Estado Mental e Demência/normas , Testes Neuropsicológicos/normas , Idoso , Idoso de 80 Anos ou mais , Disfunção Cognitiva/diagnóstico , Disfunção Cognitiva/etnologia , Avaliação Educacional , Feminino , Humanos , Líbano/etnologia , Masculino , Pessoa de Meia-Idade , Análise de Regressão
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA